MARKET NEWS

European Medicines Agency Accepts Biogen’s Aducanumab Marketing Authorization Application
Taysha Gene Therapies Bolsters Manufacturing Capacity Through Partnership 
Rubius Therapeutics Announces Dosing of First Patient with Relapsed/Refractory Acute Myeloid Leukemia in the Ongoing Phase 1/2 Clinical Trial 
Orchard Therapeutics Announces New OTL-201 Clinical Data in Sanfilippo Syndrome Type A (MPS-IIIA) Accepted for Oral Presentation
Cerevel Therapeutics Announces First Patients Dosed in all Phase 3 Trials for the Treatment of Parkinson’s Disease
Aerogen Collaborates on Development of More Than 15 Potential COVID-19 Inhaled Therapies

  FEATURED EDITORIAL

  COMPANY PROFILE

Backed by over 85 years of experience in parenterals, Baxter’s BioPharma Solutions (BPS) business collaborates with pharmaceutical companies to support commercialization objectives for their molecules. BPS is a premier CMO with a focus on injectable pharmaceutical manufacturing designed to meet complex and traditional sterile manufacturing challenges with confidence of delivery, service, and integrity. BPS can support your pharmaceutical needs with a broad portfolio of sterile fill/finish production capabilities, and our reputation is built on the high-quality products we manufacture for our clients in a cGMP environment. Click here for more.

  EXCLUSIVE ONLINE CONTENT

Novo Nordisk to Acquire Emisphere Technologies for .35 Billion

Novo Nordisk to Acquire Emisphere Technologies for $1.35 Billion

Emisphere Technologies, Inc. recently announced it has entered into a definitive agreement with Novo Nordisk, whereby Novo Nordisk will acquire Emisphere, on a cash-free, debt-free basis, for….

CymaBay Announces Study to Evaluate the Potential for GPR119 Agonists to Prevent Hypoglycemia in Type 1 Diabetes

CymaBay Announces Study to Evaluate the Potential for GPR119 Agonists to Prevent Hypoglycemia in Type 1 Diabetes

CymaBay Therapeutics, Inc. recently announced it will provide its proprietary investigational GPR119 agonist, MBX-2982, and will assist in regulatory filings for….

eGenesis Announces Research Collaboration With Leading Academic Medical Center

eGenesis Announces Research Collaboration With Leading Academic Medical Center

eGenesis recently announced the initiation of a research collaboration with Duke University School of Medicine. The collaboration will encompass evaluation of gene-edited pancreatic islet….

Calithera Biosciences Announces Expansion of Ongoing Clinical Trial

Calithera Biosciences Announces Expansion of Ongoing Clinical Trial

Calithera Biosciences, Inc. recently announced the expansion of the company’s ongoing clinical trial evaluating telaglenastat in combination with Pfizer’s CDK 4/6 inhibitor palbociclib….

APPLY NOW ! - A Novel Approach for Incentivizing Drug Delivery Innovation

APPLY NOW ! - A Novel Approach for Incentivizing Drug Delivery Innovation

One of the most critical early steps in the development of novel drug delivery systems is to demonstrate convincing proof-of-concept. The dilemma is that while pharma companies can be interested in….